Gata1s mutant mice display persistent defects in the erythroid lineage

Blood Adv. 2023 Jul 11;7(13):3253-3264. doi: 10.1182/bloodadvances.2022008124.

Abstract

GATA1 mutations that result in loss of the N-terminal 83 amino acids are a feature of myeloid leukemia in children with Down syndrome, rare familial cases of dyserythropoietic anemia, and a subset of cases of Diamond-Blackfan anemia. The Gata1s mouse model, which expresses only the short GATA1 isoform that begins at methionine 84, has been shown to have a defect in hematopoiesis, especially impaired erythropoiesis with expanded megakaryopoiesis, during gestation. However, these mice reportedly did not show any postnatal phenotype. Here, we demonstrate that Gata1s mutant mice display macrocytic anemia and features of aberrant megakaryopoiesis throughout life, culminating in profound splenomegaly and bone marrow fibrosis. These data support the use of this animal model for studies of GATA1 deficiencies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Lineage
  • Down Syndrome* / complications
  • Erythropoiesis* / genetics
  • Mice
  • Protein Isoforms
  • Thrombopoiesis

Substances

  • Protein Isoforms
  • Gata1 protein, mouse